These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serotonin (5-HT) and neuropsychiatric disorders. Donaldson D J R Soc Promot Health; 2000 Jun; 120(2):78-9. PubMed ID: 10944875 [No Abstract] [Full Text] [Related]
4. [Functional vs. nosological approach in biological psychiatry: the serotonergic dimension]. Bleich A; Van Praag HN Harefuah; 1988 Sep; 115(5-6):156-8. PubMed ID: 3192128 [No Abstract] [Full Text] [Related]
5. Serotonin in behavioural disorders. A symposium of the XVIth Collegium Internationale Neuro-psychopharmacologicum. Munich, 15-19 August 1988. Proceedings. Br J Psychiatry Suppl; 1989 Dec; (8):5-69. PubMed ID: 2611007 [No Abstract] [Full Text] [Related]
6. [5HT-moduline an new peptide specifically interactive with the serotonergic system: physiopathologic implications]. Fillion G Ann Pharm Fr; 1998; 56(4):145-7. PubMed ID: 9770005 [TBL] [Abstract][Full Text] [Related]
7. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects]. Marco Igual M Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545 [No Abstract] [Full Text] [Related]
8. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology. Carrey N; Kutcher S J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031 [No Abstract] [Full Text] [Related]
10. [Serotonin in neurology and psychiatry]. van Kempen GM Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2084-8. PubMed ID: 7477566 [No Abstract] [Full Text] [Related]
11. [Aggression and autoaggression]. Steinert T; Wolfersdorf M Psychiatr Prax; 1993 Jan; 20(1):1-8. PubMed ID: 8378472 [TBL] [Abstract][Full Text] [Related]
12. [Progress toward functional diagnosis in psychiatry. The serotonin deficiency syndrome]. Pöldinger W; Macke S Ther Umsch; 1996 Mar; 53(3):225-7. PubMed ID: 8900885 [TBL] [Abstract][Full Text] [Related]
13. Systems biology and psychiatry: the functional architecture of molecular networks in mental disorders- data and models. Editorial. Tretter F; Gallinat J; Müller WE Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S1. PubMed ID: 18756414 [No Abstract] [Full Text] [Related]
14. Serotonin-dopamine interaction: an overview. Esposito E; Di Matteo V; Di Giovanni G Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025 [TBL] [Abstract][Full Text] [Related]
15. History of serotonin and serotinin disorders. Sjoerdsma A; Palfreyman MG Ann N Y Acad Sci; 1990; 600():1-7; discussion 7-8. PubMed ID: 2252303 [No Abstract] [Full Text] [Related]
16. The developmental role of serotonin: news from mouse molecular genetics. Gaspar P; Cases O; Maroteaux L Nat Rev Neurosci; 2003 Dec; 4(12):1002-12. PubMed ID: 14618156 [TBL] [Abstract][Full Text] [Related]
17. A psychological model of mental disorder. Kinderman P Harv Rev Psychiatry; 2005; 13(4):206-17. PubMed ID: 16126607 [TBL] [Abstract][Full Text] [Related]
18. Serotonin: how much we have learned! So much to discover.. Greden JF Biol Psychiatry; 1998 Sep; 44(5):309-12. PubMed ID: 9755352 [No Abstract] [Full Text] [Related]
19. Neurobiology and psychopathological states: are we looking in the right place? Maas JW; Katz MM Biol Psychiatry; 1992 Apr; 31(8):757-8. PubMed ID: 1353690 [No Abstract] [Full Text] [Related]